Atara Biotherapeutics (ATRA) stock forecast for 2023. Forecast tables and graphs.

Atara Biotherapeutics (ATRA) stock forecast for 2023

The forecast has been updated: September 27, 2021 12:38


Atara Biotherapeutics stock price online today

Analyst Target Price

33.38

Dividend Date

-

Ex Dividend Date

-

Last Split Factor

None

Last Split Date

-

Should you buy or sell Atara Biotherapeutics stock stock today? What is the projected target price level for 2023? How much will it cost in 2023? Atara Biotherapeutics stock Stock Monthly Prediction for January, February, March, April, May, July, July, August, September, October, November and December 2023.

We predict the dynamics of the stock market value using resonant artificial intelligence systems.

Technical, fundamental analyzes, news background, general geopolitical situation in the world and other factors are taken into account.

Forecasts are adjusted once a day taking into account the price change of the previous day.

To date, analysts have a $33.38 target price for Atara Biotherapeutics stock stock.

Today 200 Day Moving Average is the support level (14.34 $).

50 Day Moving Average is the support level (14.58 $).




ATRA Forecast for 2023

Month Rate Forecast MIN Rate MAX Rate Volati-
lity, %
Jan 15.38 13.99 16.01 12.57 %
Feb 16.63 15.30 18.07 15.35 %
Mar 16.75 15.89 17.32 8.24 %
Apr 16.47 15.54 17.42 10.78 %
May 17.03 15.84 18.31 13.50 %
Jun 15.29 14.59 16.76 12.92 %
Jul 14.48 14.03 15.38 8.81 %
Aug 15.14 14.36 16.58 13.37 %
Sep 15.89 15.03 17.03 11.75 %
Oct 15.18 14.53 16.09 9.74 %
Nov 15.27 14.37 16.56 13.17 %
Dec 15.09 14.47 15.69 7.73 %

The forecasts table above shows the forecast values of the company's stock price for each month. The Rate Forecast column displays the Optimal Average Forecast Price. The MIN Rate column displays a pessimistic forecast for this month. “MAX Rate” is an optimistic forecast. The % Volatility column represents the approximate monthly volatility of Atara Biotherapeutics stock.


Atara Biotherapeutics overview

Atara Biotherapeutics Address

611 GATEWAY BLVD, SUITE 900, SOUTH SAN FRANCISCO, CA, US

Market Capitalization

1 440 879 000 $

EBITDA

-279 340 992

PE Ratio

None

PEG Ratio

0

Dividend Per Share

None

Dividend Yield

0

EPS

-3.628

Quarterly Earnings Growth YOY

0

Quarterly Revenue Growth YOY

0

Trailing PE

0

Forward PE

0

EV To Revenue

134.96

EV To EBITDA

0

52 Week High

26.1

52 Week Low

11.81

50 Day Moving Average

14.58

200 Day Moving Average

14.34

Shares Outstanding

84758000

Shares Float

61193000

Shares Short Prior Month

12220300

Short Ratio

16.78

Percent Insiders

0.571

Percent Institutions

103.19

Atara Biotherapeutics stock forecast for this year


Atara Biotherapeutics stock forecast for Jan 2023.
Estimated Average Forecasted Atara Biotherapeutics Price: 15.38. Positive monthly dynamics of the instrument is expected with 12.567% volatility is expected.

Pessimistic forecast: 13.99

Optimistic: 16.01


Atara Biotherapeutics stock forecast for Feb 2023.
Estimated Average Forecasted Atara Biotherapeutics Price: 16.63. Positive monthly dynamics of the instrument is expected with 15.353% volatility is expected.

Pessimistic forecast: 15.30

Optimistic: 18.07


Atara Biotherapeutics stock forecast for Mar 2023.
Estimated Average Forecasted Atara Biotherapeutics Price: 16.75. Positive monthly dynamics of the instrument is expected with 8.243% volatility is expected.

Pessimistic forecast: 15.89

Optimistic: 17.32


Atara Biotherapeutics stock forecast for Apr 2023.
Estimated Average Forecasted Atara Biotherapeutics Price: 16.47. Negative monthly dynamics of the instrument is expected with 10.779% volatility is expected.

Pessimistic forecast: 15.54

Optimistic: 17.42


Atara Biotherapeutics stock forecast for May 2023.
Estimated Average Forecasted Atara Biotherapeutics Price: 17.03. Positive monthly dynamics of the instrument is expected with 13.500% volatility is expected.

Pessimistic forecast: 15.84

Optimistic: 18.31


Atara Biotherapeutics stock forecast for Jun 2023.
Estimated Average Forecasted Atara Biotherapeutics Price: 15.29. Negative monthly dynamics of the instrument is expected with 12.919% volatility is expected.

Pessimistic forecast: 14.59

Optimistic: 16.76


Atara Biotherapeutics stock forecast for Jul 2023.
Estimated Average Forecasted Atara Biotherapeutics Price: 14.48. Negative monthly dynamics of the instrument is expected with 8.810% volatility is expected.

Pessimistic forecast: 14.03

Optimistic: 15.38


Atara Biotherapeutics stock forecast for Aug 2023.
Estimated Average Forecasted Atara Biotherapeutics Price: 15.14. Positive monthly dynamics of the instrument is expected with 13.373% volatility is expected.

Pessimistic forecast: 14.36

Optimistic: 16.58


Atara Biotherapeutics stock forecast for Sep 2023.
Estimated Average Forecasted Atara Biotherapeutics Price: 15.89. Positive monthly dynamics of the instrument is expected with 11.754% volatility is expected.

Pessimistic forecast: 15.03

Optimistic: 17.03


Atara Biotherapeutics stock forecast for Oct 2023.
Estimated Average Forecasted Atara Biotherapeutics Price: 15.18. Negative monthly dynamics of the instrument is expected with 9.736% volatility is expected.

Pessimistic forecast: 14.53

Optimistic: 16.09


Atara Biotherapeutics stock forecast for Nov 2023.
Estimated Average Forecasted Atara Biotherapeutics Price: 15.27. Positive monthly dynamics of the instrument is expected with 13.174% volatility is expected.

Pessimistic forecast: 14.37

Optimistic: 16.56


Atara Biotherapeutics stock forecast for Dec 2023.
Estimated Average Forecasted Atara Biotherapeutics Price: 15.09. Negative monthly dynamics of the instrument is expected with 7.734% volatility is expected.

Pessimistic forecast: 14.47

Optimistic: 15.69



Other Healthcare sector assets

Name Symbol Last Close Price Change
Abbott Laboratories
ABT 124.37 (24.09.2021) -0.74 %
AbbVie Inc.
ABBV 107.07 (24.09.2021) -0.27 %
Aeterna Zentaris Inc.
AEZS 0.602564 (24.09.2021) -3.68 %
Allakos Inc.
ALLK 108.17 (24.09.2021) -2.05 %
Allogene Therapeutics, Inc.
ALLO 25.66 (24.09.2021) -7.16 %
Amgen Inc.
AMGN 213.61 (24.09.2021) -0.67 %
Aphria Inc.
APHA 15.38 (07.05.2021) 0.00 %
Atara Biotherapeutics, Inc.
ATRA 17 (24.09.2021) -1.73 %
Aurora Cannabis Inc.
ACB 5.95 (24.09.2021) -3.25 %
Becton Dickinson and Company
BDX 253.18 (24.09.2021) -0.25 %
Biogen Inc.
BIIB 291.71 (24.09.2021) -0.51 %
Biohaven Pharmaceutical Holding Company Ltd.
BHVN 133.38 (24.09.2021) -1.60 %
BioNTech SE
BNTX 333.48 (24.09.2021) -5.53 %
bluebird bio, Inc.
BLUE 18.44 (24.09.2021) -1.18 %
Boston Scientific Corp.
BSX 44.7 (24.09.2021) -0.67 %
Bristol-Myers Squibb Company
BMY 60.23 (24.09.2021) -0.66 %
Canopy Growth Corp.
CGC 13.91 (24.09.2021) -4.46 %
Castle Biosciences, Inc.
CSTL 72.44 (24.09.2021) -3.35 %
CLOVER HEALTH INVESTMENTS, CORP
CLOV 7.73 (24.09.2021) -2.15 %
Eli Lilly and Company
LLY 231.68 (24.09.2021) -0.22 %
Emergent BioSolutions Inc.
EBS 52.39 (24.09.2021) -2.69 %
Exelixis, Inc.
EXEL 20.35 (24.09.2021) -0.73 %
G1 Therapeutics, Inc.
GTHX 15.1 (24.09.2021) -1.44 %
Gilead Sciences, Inc.
GILD 71.19 (24.09.2021) -0.70 %
GlaxoSmithKline plc
GSK 38.39 (24.09.2021) -2.41 %
GoodRx Holdings, Inc.
GDRX 44.13 (24.09.2021) -4.75 %
GW Pharmaceuticals plc.
GWPH 218.96 (05.05.2021) 0.00 %
Incyte Corp.
INCY 69 (24.09.2021) -1.12 %
Inovio Pharmaceuticals, Inc.
INO 7.76 (24.09.2021) -3.36 %
Johnson & Johnson
JNJ 164.36 (24.09.2021) -0.30 %
Medtronic plc.
MDT 130.02 (24.09.2021) -0.47 %
Merck & Co., Inc.
MRK 73.61 (24.09.2021) 0.77 %
Moderna, Inc.
MRNA 430.14 (24.09.2021) -5.38 %
Novartis AG
NVS 82.93 (24.09.2021) -0.77 %
Novavax, Inc.
NVAX 248.16 (24.09.2021) -3.55 %
ObsEva SA
OBSV 3.15 (24.09.2021) -0.32 %
OrganiGram Holdings Inc.
OGI 2.42 (24.09.2021) -3.20 %
Pfizer Inc.
PFE 43.94 (24.09.2021) -0.57 %
Regeneron Pharmaceuticals, Inc.
REGN 638.9 (24.09.2021) -1.18 %
Sanofi
SNY 47.94 (24.09.2021) -1.60 %
Schrodinger, Inc.
SDGR 57.95 (24.09.2021) -4.23 %
Senseonics Holdings, Inc.
SENS 3.57 (24.09.2021) -4.29 %
Sorrento Therapeutics, Inc.
SRNE 7.83 (24.09.2021) -3.09 %
Stryker Corp.
SYK 276.64 (24.09.2021) 0.17 %
Sundial Growers Inc.
SNDL 0.673 (24.09.2021) -4.06 %
Teva Pharmaceutical Industries Lim. (TEVA)
TEVA 8.95 (24.09.2021) -1.10 %
Thermo Fisher Scientific Inc.
TMO 609.78 (24.09.2021) 0.25 %
Tilray, Inc.
TLRY 11.67 (24.09.2021) -2.91 %
UnitedHealth Group, Inc.
UNH 407.08 (24.09.2021) -0.23 %
Veeva Systems Inc.
VEEV 299.93 (24.09.2021) 0.41 %
Zomedica Corp.
ZOM 0.5178 (24.09.2021) -2.30 %
Zynerba Pharmaceuticals, Inc.
ZYNE 4.46 (24.09.2021) -1.55 %


Denial of responsibility:

The portal leoprophet.com is not responsible for the loss of your money as a result of your use of the information contained on the site, including data, quotes, charts and forecasts. Operations in the stock, foreign exchange and commodity markets involve a high level of risk, and you are solely responsible for your operations. Only speculate with money that you can afford to lose. All prices and forecasts for stocks, indices, futures are indicative and should not be trade dependent. The portal is not responsible for any losses that you may incur as a result of using this data.